Understand the blueprint for the development of biomedical industry in the '14th Five-Year Plan'
On March 11, 2021, the Fourth Session of the Thirteenth National People’s Congress voted and passed the "The Fourteenth Five-Year Plan for the National Economic and Social Development of the People’s Republic of China (2021-2025) and the Outline of Vision Goals for 2035" (hereinafter referred to as National "Planning Outline"). On March 12, 2021, the full text of the National Planning Outline was officially announced. This outline mainly clarifies the national strategic intent, clarifies the focus of government work, and guides and regulates the behavior of market entities. It is a grand blueprint for my country to embark on a new journey of comprehensively building a modern socialist country. It is a common action plan for people of all ethnic groups across the country. In the next step, each industry will break down detailed tasks, formulate special plans, establish a major project library, and implement the national "Planning Outline". Let's also take stock of the key words of the biomedical industry in the fourteenth five-year period (2021-2025), as well as the outlook for the long-term goal of 2035.
1. Key words of the biomedical industry in the fourteenth five-year period (2021-2025)
(1) Development positioning-strategic emerging industries
Strategic emerging industries are an important force to guide future economic and social development. Accelerating the cultivation and development of strategic emerging industries is a major measure for my country to promote the upgrading of industrial structure and accelerate the transformation of economic development mode, the fourteenth five-year period (2021-2025) The plan focuses on seizing opportunities for future industrial development, cultivating leading and pillar industries, and promoting the integration, clustering, and ecological development of strategic emerging industries. The added value of strategic emerging industries accounts for more than 17% of GDP.
(2) Adhere to innovation-driven-optimize top-level design, strengthen national strategic scientific and technological strength
The second part of the National Planning Outline adheres to the core position of innovation in the overall situation of my country’s modernization drive, takes scientific and technological self-reliance as a strategic support for national development, faces the frontiers of world science and technology, faces the main economic battlefield, faces major national needs, and faces people’s lives and health , In-depth implementation of the strategy of rejuvenating the country through science and education, the strategy of strengthening the country with talents, and the strategy of innovation-driven development, improving the national innovation system, accelerating the construction of a strong country with science and technology, integrating and optimizing the allocation of scientific and technological resources, and promoting the optimization of the innovation system based on the strategic needs of the country, and speeding up the construction of a national experiment The room is a leading strategic technological force. Focus on quantum information, photonics and micro-nano electronics, network communications, artificial intelligence, biomedicine, modern energy systems and other major innovation fields to establish a number of national laboratories, reorganize the state key laboratories, and form a laboratory system with a reasonable structure and efficient operation.
(3) Key development directions
The fourteenth five-year (2021-2025) plan is to form and expand the capacity of the entire industry chain from scientific research to finished medicine in the field of biomedical industry innovation, and strengthen the in-depth R&D and generalization of technologies such as gene therapy, cell therapy, and immunotherapy化 Application.
2. Prospects for long-term goals in 2035
Looking forward to 2035, my country will basically realize socialist modernization. Economic strength, scientific and technological strength, and overall national strength will rise sharply, the total economic output and the per capita income of urban and rural residents will reach a new level, the key core technology will achieve major breakthroughs, and it will enter the forefront of innovative countries. Basically realize new industrialization, informatization, urbanization, and agricultural modernization, and establish a modern economic system. Build a country strong in culture, education, talent, sports, and healthy China. The quality of the people and the level of social civilization will reach new heights. The author hopes that by 2035, China will become the world's biomedical industry innovation highland and an important gathering place for high-end talents in the biomedical industry to innovate and start businesses.
Looking for chemical products? Let suppliers reach out to you!
2026-05-18
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Structure Of Supply Chain Of Pharmaceutical Products
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
Recommend Reading
-
Sun Pharma Invests 100 Million Dollars to Launch Breakthrough Specialty Drugs
-
Glenmark’s ISB 2001 Achieves 79 Percent Response Rate in Multiple Myeloma Trial
-
Trump’s Drug Price Cuts to Have Minimal Impact on Indian Pharma Exports Says Crisil Ratings
-
Pfizer and US Government Discuss Drug Prices No Firm Commitments Yet
-
Merck’s Enlicitide Decanoate Achieves Key Breakthrough in Cholesterol Trials
-
Soybean Prices Rise Globally as Trade Talks and USDA Report Loom
-
This week, the polyester bottle chip market in China showed a trend of first declining then rising (10.20-24)
-
July 9 Tariff Deadline Looms as Tuna Prices Decline Globally
-
This Week's PVC Market Stabilizes in China (10.20-24)
-
China to Resume Japanese Seafood Imports After Two Year Ban